Literature DB >> 28698662

The extracellular matrix of the gastrointestinal tract: a regenerative medicine platform.

George S Hussey1,2, Timothy J Keane3, Stephen F Badylak1,2.   

Abstract

The synthesis and secretion of components that constitute the extracellular matrix (ECM) by resident cell types occur at the earliest stages of embryonic development, and continue throughout life in both healthy and diseased physiological states. The ECM consists of a complex mixture of insoluble and soluble functional components that are arranged in a tissue-specific 3D ultrastructure, and it regulates numerous biological processes, including angiogenesis, innervation and stem cell differentiation. Owing to its composition and influence on embryonic development, as well as cellular and organ homeostasis, the ECM is an ideal therapeutic substrate for the repair of damaged or diseased tissues. Biologic scaffold materials that are composed of ECM have been used in various surgical and tissue-engineering applications. The gastrointestinal (GI) tract presents distinct challenges, such as diverse pH conditions and the requirement for motility and nutrient absorption. Despite these challenges, the use of homologous and heterologous ECM bioscaffolds for the focal or segmental reconstruction and regeneration of GI tissue has shown promise in early preclinical and clinical studies. This Review discusses the importance of tissue-specific ECM bioscaffolds and highlights the major advances that have been made in regenerative medicine strategies for the reconstruction of functional GI tissues.

Entities:  

Mesh:

Year:  2017        PMID: 28698662     DOI: 10.1038/nrgastro.2017.76

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  217 in total

1.  Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response.

Authors:  A J Allman; T B McPherson; S F Badylak; L C Merrill; B Kallakury; C Sheehan; R H Raeder; D W Metzger
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

2.  Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains.

Authors:  A Leinonen; M Mariyama; T Mochizuki; K Tryggvason; S T Reeders
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

3.  The Effect of Mechanical Loading Upon Extracellular Matrix Bioscaffold-Mediated Skeletal Muscle Remodeling.

Authors:  Jenna L Dziki; Ross M Giglio; Brian M Sicari; Derek S Wang; Riddhi M Gandhi; Ricardo Londono; Christopher L Dearth; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-04-19       Impact factor: 3.845

4.  Treatment of fistula-in-ano using a porcine small intestinal submucosa anal fistula plug.

Authors:  J R Cintron; H Abcarian; V Chaudhry; M Singer; S Hunt; E Birnbaum; M G Mutch; J Fleshman
Journal:  Tech Coloproctol       Date:  2012-09-28       Impact factor: 3.781

5.  Biologic scaffold remodeling in a dog model of complex musculoskeletal injury.

Authors:  Neill J Turner; John S Badylak; Douglas J Weber; Stephen F Badylak
Journal:  J Surg Res       Date:  2011-12-15       Impact factor: 2.192

6.  Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering.

Authors:  Peter M Crapo; Stephen Tottey; Peter F Slivka; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2013-10-10       Impact factor: 3.845

7.  Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery.

Authors:  Michael Stumpf; Uwe Klinge; Arnulf Wilms; Robert Zabrocki; Rafael Rosch; Karsten Junge; Carsten Krones; Volker Schumpelick
Journal:  Surgery       Date:  2005-02       Impact factor: 3.982

8.  Expression of tenascin in the developing human small intestine.

Authors:  J F Beaulieu; S Jutras; M Kusakabe; N Perreault
Journal:  Biochem Biophys Res Commun       Date:  1993-05-14       Impact factor: 3.575

9.  In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.

Authors:  Maelene L Wong; Janelle L Wong; Natalia Vapniarsky; Leigh G Griffiths
Journal:  Biomaterials       Date:  2016-03-19       Impact factor: 12.479

Review 10.  Effects of matrix metalloproteinases on the fate of mesenchymal stem cells.

Authors:  Sami G Almalki; Devendra K Agrawal
Journal:  Stem Cell Res Ther       Date:  2016-09-09       Impact factor: 6.832

View more
  25 in total

1.  Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair.

Authors:  Jeffrey J D Henry; Lawrence Delrosario; Jun Fang; Sze Yue Wong; Qizhi Fang; Richard Sievers; Surya Kotha; Aijun Wang; Diana Farmer; Praneeth Janaswamy; Randall J Lee; Song Li
Journal:  Adv Healthc Mater       Date:  2019-11-28       Impact factor: 9.933

2.  A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn's Disease and DSS Colitis.

Authors:  Majken Lindholm; Antonio Di Sabatino; Tina Manon-Jensen; Giuseppe Mazza; Gunvor I Madsen; Paolo Giuffrida; Massimo Pinzani; Aleksander Krag; Morten A Karsdal; Jens Kjeldsen; Joachim H Mortensen
Journal:  Dig Dis Sci       Date:  2021-09-24       Impact factor: 3.487

Review 3.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

4.  Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

Authors:  Yang Zhu; Sato Hideyoshi; Hongbin Jiang; Yasumoto Matsumura; Jenna L Dziki; Samuel T LoPresti; Luai Huleihel; Gabriela N F Faria; Leah C Fuhrman; Ricardo Lodono; Stephen F Badylak; William R Wagner
Journal:  Acta Biomater       Date:  2018-04-10       Impact factor: 8.947

5.  Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway.

Authors:  George S Hussey; Jenna L Dziki; Yoojin C Lee; Joseph G Bartolacci; Marissa Behun; Hēth R Turnquist; Stephen F Badylak
Journal:  J Immunol Regen Med       Date:  2019-02-01

6.  Novel Marine Organism-Derived Extracellular Vesicles for Control of Anti-Inflammation.

Authors:  Sung-Han Jo; Changsu Kim; Sang-Hyug Park
Journal:  Tissue Eng Regen Med       Date:  2021-01-07       Impact factor: 4.169

Review 7.  Gut bioengineering strategies for regenerative medicine.

Authors:  John D O'Neill; Meghan R Pinezich; Brandon A Guenthart; Gordana Vunjak-Novakovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-11       Impact factor: 4.052

8.  Using Acellular Bioactive Extracellular Matrix Scaffolds to Enhance Endogenous Cardiac Repair.

Authors:  Daniyil A Svystonyuk; Holly E M Mewhort; Paul W M Fedak
Journal:  Front Cardiovasc Med       Date:  2018-04-11

9.  Esophageal extracellular matrix hydrogel mitigates metaplastic change in a dog model of Barrett's esophagus.

Authors:  Juan Diego Naranjo; Lindsey T Saldin; Eric Sobieski; Lina M Quijano; Ryan C Hill; Patrick G Chan; Crisanto Torres; Jenna L Dziki; Madeline C Cramer; Yoojin C Lee; Rohit Das; Anant K Bajwa; Rania Nossair; Molly Klimak; Lucile Marchal; Shil Patel; Sachin S Velankar; Kirk C Hansen; Kevin McGrath; Stephen F Badylak
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

10.  Development of immortalized Hertwig's epithelial root sheath cell lines for cementum and dentin regeneration.

Authors:  Xuebing Li; Sicheng Zhang; Zirui Zhang; Weihua Guo; Guoqing Chen; Weidong Tian
Journal:  Stem Cell Res Ther       Date:  2019-01-03       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.